These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6726633)

  • 1. Absorption of phenobarbital from tablets and elixir.
    Meyer MC; Straughn AB; Raghow G; Schary WL; Rotenberg KS
    J Pharm Sci; 1984 Apr; 73(4):485-8. PubMed ID: 6726633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.
    Shen DD; Fixley M; Azarnoff DL
    J Pharm Sci; 1978 Jul; 67(7):916-9. PubMed ID: 660507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo characteristics of some commercial phenobarbital tablets.
    Sylvestri MF; Ueda CT
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute and relative bioavailability of oral acetaminophen preparations.
    Ameer B; Divoll M; Abernethy DR; Greenblatt DJ; Shargel L
    J Pharm Sci; 1983 Aug; 72(8):955-8. PubMed ID: 6688635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
    Johnson BF; Bye C
    Br Heart J; 1975 Feb; 37(2):203-8. PubMed ID: 1091283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of sulfadiazine solutions, suspensions, and tablets in humans.
    Meyer MC; Straughn AB; Ramachander G; Cavagnol JC; Biola Mabadeje AF
    J Pharm Sci; 1978 Dec; 67(12):1659-61. PubMed ID: 581498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
    Harrison LI; French IW; Mildon CA
    Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability of acetazolamide tablets.
    Straughn AB; Gollamudi R; Meyer MC
    Biopharm Drug Dispos; 1982; 3(1):75-82. PubMed ID: 7082781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiple-dose study of sustained-release theophylline and aminophylline.
    Meyer MC; Straughn AB; Lieberman P
    Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
    Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A
    Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and dissolution parameters of seven lithium carbonate products.
    Needham TE; Javid P; Brown W
    J Pharm Sci; 1979 Aug; 68(8):952-4. PubMed ID: 480173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.